ALLI

Compare ALLI  to:
Compare
Compare

Generic Name for ALLI

Orlistat 60mg; caps.

Legal Classification:

OTC

Pharmacological Class for ALLI

Lipase inhibitor.

Manufacturer of ALLI

GlaxoSmithKline Pharmaceuticals

Indications for ALLI

Adjunct to reduced-calorie, low-fat diet for weight loss in overweight adults.

Adult dose for ALLI

≥18yrs: 1 cap with each fat-containing meal. Max: 180mg/day. Also, take a multivitamin once daily at bedtime.

Children's dosing for ALLI

<18yrs: not recommended.

Contraindications for ALLI

Organ transplant. Chronic malabsorption syndrome. Cholestasis.

Warnings/Precautions for ALLI

Gallbladder disorder. Pancreatitis. Kidney stones. Pregnancy, nursing mothers: not recommended.

Interactions for ALLI

Concomitant cyclosporine: not recommended. May decrease absorption of fat-soluble vitamins; supplement diet with a multivitamin (separate dosing by at least 2 hours). Monitor warfarin, antidiabetics, thyroid drugs; may need to adjust dose.

Adverse Reactions for ALLI

GI effects (oily spotting, flatus with discharge, fecal urgency, fatty/oily stools, oily evacuation, increased defecation, fecal incontinence).

How is ALLI supplied?

Caps—60, 90, 120

Related Disease:

Obesity

Related Resources

Solo Slim weight loss supplement recalled

August 09, 2010

EZVille and the FDA announced a recall of all lots of Solo Slim and Solo Slim Extra Strength capsules after FDA lab analyses showed the products to contain undeclared didesmethyl sibutramine.

FDA warns of dangerous ingredients in Joyful Slim herb supplement

July 22, 2010

The FDA is warning consumers that Joyful Slim herb supplement, marketed as a natural herb for weight loss, contains undeclared desmethyl sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss.

FDA warns of dangerous ingredients in Slim-30 Herb Supplement

July 19, 2010

The FDA is warning consumers that Slim-30 Herb Supplement, an appetite suppressant for weight loss, contains undeclared N-Desmethyl sibutramine and traces of sibutramine.

FDA warns against Que She herbal supplement

July 08, 2010

The FDA has warned consumers and healthcare professionals that Que She, marketed as "Slimming Factor Capsule," an herbal weight loss supplement, contains undeclared ingredients that could harm consumers, especially those with cardiovascular conditions.

New data announced for Contrave for the treatment of obesity associated with type 2 diabetes

June 28, 2010

Orexigen announced data from its COR-Diabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) for weight lowering and improved glycemic control in obese patients with type 2 diabetes.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions